Lexicon Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Lexicon Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 0.58 in the third quarter 2026, unsurprisingly, as the Lexicon Pharmaceuticals Inc markets continue to deteriorate, and LXRX's faces growing challenges to bring down its inventories. Lexicon Pharmaceuticals Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 629 days, from 487 days, in the Jun 30 2026 quarter.

Within Healthcare sector 349 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1451 in the second quarter 2026, to 1699.

LXRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lexicon Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LXRX Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	663.29 %	611.9 %	37.31 %	21.65 %	-75.16 %
Y / Y Cost of Sales Growth	690 %	18.18 %	260 %	-42.24 %	-85.92 %
Inventory Turnover Ratio (TTM)	0.58	0.75	1.59	1.36	2.22
LXRX's Total Ranking	# 1699	# 1451	# 1001	# 1077	#
Average inventory processing period	632	487	229	269	164
Seq. Inventory Growth	0.84 %	333.33 %	-1.78 %	77.85 %	-5.95 %
Seq. Cost of Sales Growth	102.56 %	-63.89 %	-46.27 %	1910 %	-69.7 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 109
Healthcare Sector	# 350
Overall Market	# 1699

Inventory Turnover Ratio Statistics
High	Average	Low
2.22	1	0.33
(Sep 30 2025)		(Mar 31 2024)

LXRX Company Profile >> Back to LXRX Efficiency Comparisons >> Compare LXRX Inventory Turnover Ratio to its Competitors

Financial Statements
Lexicon Pharmaceuticals Inc 's Inventories	$ 1 Millions	Visit LXRX's Balance sheet
Lexicon Pharmaceuticals Inc 's Cost of Revenues TTM	$ 0 Millions	Visit LXRX's Income Statement
What are LXRX's Sales?		Visit LXRX's Sales by Segment

Other Inventory Turnover Ratios
Lexicon Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LXRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LXRX's Competitors
Inventory Turnover Ratio for LXRX's Suppliers
Inventory Turnover Ratio for LXRX's Customers

You may also want to know
LXRX's Sales Growth Rates	LXRX's Pe Price to earnings ratio	LXRX's Receivables Turnover Ratio	LXRX's Stock Quote
LXRX's Net Income Growth Rates	LXRX's Ps Price to Sales ratio	LXRX's Sales per Employee	LXRX's Asset Turnover Ratio
LXRX's Net Margin	LXRX's Pb Price to Book ratio	LXRX's Financial Strength Ratios	LXRX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Amarin Corp Plcuk	0.92	$ 104.502 Millions	$ 113 Millions
Eli Lilly And Company	0.89	$ 14,149.700 Millions	$ 15,815 Millions
Cerus Corporation	0.87	$ 54.000 Millions	$ 62 Millions
Rxsight Inc	0.82	$ 29.342 Millions	$ 36 Millions
Profound Medical Corp	0.79	$ 6.177 Millions	$ 8 Millions
Inspire Medical Systems inc	0.74	$ 122.959 Millions	$ 165 Millions
Butterfly Network Inc	0.62	$ 37.120 Millions	$ 60 Millions
Regeneron Pharmaceuticals Inc	0.60	$ 1,842.200 Millions	$ 3,071 Millions
Lenz Therapeutics Inc	0.58	$ 2.228 Millions	$ 4 Millions
Lexicon Pharmaceuticals Inc	0.58	$ 0.427 Millions	$ 1 Millions
Biomarin Pharmaceutical Inc	0.57	$ 878.919 Millions	$ 1,538 Millions
Verastem Inc	0.51	$ 1.117 Millions	$ 2 Millions
Orthopediatrics Corp	0.50	$ 68.827 Millions	$ 137 Millions
Travere Therapeutics Inc	0.40	$ 9.545 Millions	$ 24 Millions
Ardelyx inc	0.31	$ 25.958 Millions	$ 84 Millions
Madrigal Pharmaceuticals Inc	0.10	$ 10.400 Millions	$ 102 Millions

Date modified: 2026-11-09T06:44:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.